Published in Am J Hum Genet on February 19, 2007
Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell (2008) 9.59
Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet (2009) 5.84
Activated STING in a vascular and pulmonary syndrome. N Engl J Med (2014) 4.67
Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity (2012) 3.49
Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum Mol Genet (2009) 3.07
Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet (2014) 2.88
Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet (2007) 2.81
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat Genet (2012) 2.63
Recent advances in the genetics of autoimmune disease. Annu Rev Immunol (2009) 2.41
A genomic approach to human autoimmune diseases. Annu Rev Immunol (2010) 2.10
Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun (2011) 1.70
The TREX1 double-stranded DNA degradation activity is defective in dominant mutations associated with autoimmune disease. J Biol Chem (2008) 1.58
Unusual cutaneous features associated with a heterozygous gain-of-function mutation in IFIH1: overlap between Aicardi-Goutières and Singleton-Merten syndromes. Br J Dermatol (2015) 1.57
Innate and adaptive immune response to apoptotic cells. J Autoimmun (2007) 1.42
New roles for the major human 3'-5' exonuclease TREX1 in human disease. Cell Cycle (2008) 1.35
Mouse SAMHD1 has antiretroviral activity and suppresses a spontaneous cell-intrinsic antiviral response. Cell Rep (2013) 1.28
The enemy within: endogenous retroelements and autoimmune disease. Nat Immunol (2014) 1.27
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity. J Clin Invest (2014) 1.25
Do all of the neurologic diseases in patients with DNA repair gene mutations result from the accumulation of DNA damage? DNA Repair (Amst) (2008) 1.25
An autoimmune disease prevented by anti-retroviral drugs. Retrovirology (2011) 1.25
Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am J Med Genet A (2015) 1.17
Dominant mutation of the TREX1 exonuclease gene in lupus and Aicardi-Goutieres syndrome. J Biol Chem (2011) 1.15
Cutting Edge: cGAS Is Required for Lethal Autoimmune Disease in the Trex1-Deficient Mouse Model of Aicardi-Goutières Syndrome. J Immunol (2015) 1.14
Aicardi-Goutières syndrome: a model disease for systemic autoimmunity. Clin Exp Immunol (2014) 1.10
RNaseH2 mutants that cause Aicardi-Goutieres syndrome are active nucleases. J Mol Med (Berl) (2008) 1.09
Interferon-alpha: a therapeutic target in systemic lupus erythematosus. Rheum Dis Clin North Am (2010) 1.08
Therapies in Aicardi-Goutières syndrome. Clin Exp Immunol (2014) 1.07
Endogenous retroelements and autoimmune disease. Curr Opin Immunol (2012) 1.06
The structure of the mammalian RNase H2 complex provides insight into RNA.NA hybrid processing to prevent immune dysfunction. J Biol Chem (2009) 1.06
Connections between antiviral defense and autoimmunity. Curr Opin Immunol (2009) 1.05
Nucleic Acid sensors and type I interferon production in systemic lupus erythematosus. Front Immunol (2013) 1.04
Lenalidomide therapy in treatment-refractory cutaneous lupus erythematosus: histologic and circulating leukocyte profile and potential risk of a systemic lupus flare. J Am Acad Dermatol (2011) 1.02
RNA degradation in antiviral immunity and autoimmunity. Trends Immunol (2015) 1.01
The TREX1 exonuclease R114H mutation in Aicardi-Goutières syndrome and lupus reveals dimeric structure requirements for DNA degradation activity. J Biol Chem (2011) 1.01
Early onset of autoimmune disease by the retroviral integrase inhibitor raltegravir. Proc Natl Acad Sci U S A (2009) 0.99
Cooperative DNA binding and communication across the dimer interface in the TREX2 3' --> 5'-exonuclease. J Biol Chem (2008) 0.99
Chilblain lupus erythematosus--a review of literature. Clin Rheumatol (2008) 0.99
The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score. Br J Dermatol (2012) 0.97
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome. Elife (2015) 0.96
Reaction mechanism of the epsilon subunit of E. coli DNA polymerase III: insights into active site metal coordination and catalytically significant residues. J Am Chem Soc (2009) 0.95
Endogenous retroviral pathogenesis in lupus. Curr Opin Rheumatol (2010) 0.95
Human disease phenotypes associated with mutations in TREX1. J Clin Immunol (2015) 0.93
Advances in lupus genetics. Curr Opin Rheumatol (2015) 0.92
STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells. J Immunol (2014) 0.91
Vicious circle: systemic autoreactivity in Ro52/TRIM21-deficient mice. J Exp Med (2009) 0.89
Three prime exonuclease I (TREX1) is Fos/AP-1 regulated by genotoxic stress and protects against ultraviolet light and benzo(a)pyrene-induced DNA damage. Nucleic Acids Res (2010) 0.89
DNA binding induces active site conformational change in the human TREX2 3'-exonuclease. Nucleic Acids Res (2009) 0.88
TREX1 acts in degrading damaged DNA from drug-treated tumor cells. DNA Repair (Amst) (2009) 0.88
Developments in the clinical understanding of lupus. Arthritis Res Ther (2009) 0.86
Modes of retrotransposition of long interspersed element-1 by environmental factors. Front Microbiol (2012) 0.85
Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus. Dis Model Mech (2014) 0.84
Type I interferon dysregulation and neurological disease. Nat Rev Neurol (2015) 0.84
The TREX1 C-terminal region controls cellular localization through ubiquitination. J Biol Chem (2013) 0.83
Defects in DNA degradation revealed in crystal structures of TREX1 exonuclease mutations linked to autoimmune disease. DNA Repair (Amst) (2011) 0.83
Structural and biochemical studies of TREX1 inhibition by metals. Identification of a new active histidine conserved in DEDDh exonucleases. Protein Sci (2008) 0.82
The 3'-5' DNA exonuclease TREX1 directly interacts with poly(ADP-ribose) polymerase-1 (PARP1) during the DNA damage response. J Biol Chem (2014) 0.82
Deregulated type I IFN response in TREX1-associated familial chilblain lupus. J Invest Dermatol (2013) 0.81
Animal Models of Interferon Signature Positive Lupus. Front Immunol (2015) 0.81
Genetics of SLE: functional relevance for monocytes/macrophages in disease. Clin Dev Immunol (2012) 0.81
New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol (2016) 0.81
TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy. Neurol Sci (2014) 0.80
RPA and Rad51 constitute a cell intrinsic mechanism to protect the cytosol from self DNA. Nat Commun (2016) 0.80
Type I interferonopathies in pediatric rheumatology. Pediatr Rheumatol Online J (2016) 0.80
Restricting retrotransposons: a review. Mob DNA (2016) 0.79
Type I interferonopathies--an expanding disease spectrum of immunodysregulation. Semin Immunopathol (2015) 0.79
Blood gene expression profiling in pediatric systemic lupus erythematosus and systemic juvenile idiopathic arthritis: from bench to bedside. Pediatr Rheumatol Online J (2014) 0.79
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations. Brain (2016) 0.79
Spontaneous activation of RNA-sensing pathways in autoimmune disease. Curr Opin Immunol (2013) 0.78
Family history of autoimmune disease in patients with Aicardi-Goutières syndrome. Clin Dev Immunol (2012) 0.78
Activation of STING requires palmitoylation at the Golgi. Nat Commun (2016) 0.78
The Arg-62 residues of the TREX1 exonuclease act across the dimer interface contributing to catalysis in the opposing protomers. J Biol Chem (2014) 0.77
How SLX4 cuts through the mystery of HIV-1 Vpr-mediated cell cycle arrest. Retrovirology (2014) 0.77
IFNαR signaling in effector but not regulatory T cells is required for immune dysregulation during type I IFN-dependent inflammatory disease. J Immunol (2014) 0.77
Human DNA Exonuclease TREX1 Is Also an Exoribonuclease That Acts on Single-stranded RNA. J Biol Chem (2015) 0.77
A TREX1 mutation causing cerebral vasculopathy in a patient with familial chilblain lupus. J Neurol (2013) 0.76
Immune sensing of nucleic acids in inflammatory skin diseases. Semin Immunopathol (2014) 0.76
Immunogenetics of cutaneous lupus erythematosus. Curr Opin Pediatr (2016) 0.76
Aicardi-Goutières syndrome protein TREX1 suppresses L1 and maintains genome integrity through exonuclease-independent ORF1p depletion. Nucleic Acids Res (2017) 0.75
DNA repair and systemic lupus erythematosus. DNA Repair (Amst) (2017) 0.75
Small molecule inhibition of cGAS reduces interferon expression in primary macrophages from autoimmune mice. Nat Commun (2017) 0.75
[Familial chilblain lupus : Type 1 interferonopathy with model character]. Z Rheumatol (2017) 0.75
Aicardi-Goutières syndrome with emphasis on sonographic features in infancy. Pediatr Radiol (2012) 0.75
Tocilizumab reverses cerebral vasculopathy in a patient with homozygous SAMHD1 mutation. Clin Rheumatol (2017) 0.75
Solving the genetic puzzle of systemic lupus erythematosus. Pediatr Nephrol (2014) 0.75
Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat Genet (2006) 6.15
Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity (2006) 5.47
Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection. Nat Genet (2006) 5.26
Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet (2001) 3.21
Gene-targeted mice lacking the Trex1 (DNase III) 3'-->5' DNA exonuclease develop inflammatory myocarditis. Mol Cell Biol (2004) 3.19
Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature (2006) 2.82
Familial systemic lupus erythematosus and congenital infection-like syndrome. Neuropediatrics (2000) 2.49
Cerebral thrombotic microangiopathy and antiphospholipid antibodies in Aicardi-Goutieres syndrome--report of two sisters. Neuropediatrics (2005) 2.44
Identification and expression of the TREX1 and TREX2 cDNA sequences encoding mammalian 3'-->5' exonucleases. J Biol Chem (1999) 2.26
The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death. Mol Cell (2006) 2.21
Excision of 3' termini by the Trex1 and TREX2 3'-->5' exonucleases. Characterization of the recombinant proteins. J Biol Chem (2001) 2.15
A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein. EMBO J (1999) 2.04
Aicardi-Goutières syndrome: an update and results of interferon-alpha studies. Ann Neurol (1998) 1.61
Properties of deoxyribonuclease 3 from mammalian tissues. J Biol Chem (1969) 1.55
Cree encephalitis is allelic with Aicardi-Goutiéres syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism. J Med Genet (2003) 1.53
Phenotypic overlap between infantile systemic lupus erythematosus and Aicardi-Goutières syndrome. Neuropediatrics (2005) 1.41
Systemic lupus erythematosus or Aicardi-Goutières syndrome? Neuropediatrics (2000) 1.37
The human TREX2 3' -> 5'-exonuclease structure suggests a mechanism for efficient nonprocessive DNA catalysis. J Biol Chem (2005) 1.36
Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p. Am J Hum Genet (2006) 1.34
The Aicardi-Goutières syndrome (familial, early onset encephalopathy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis). J Med Genet (1995) 1.28
Aicardi-Goutières syndrome displays genetic heterogeneity with one locus (AGS1) on chromosome 3p21. Am J Hum Genet (2000) 1.03
Apoptotic cell death and lupus. Springer Semin Immunopathol (2006) 1.02
Sequence variants in the 3'-->5' deoxyribonuclease TREX2: identification in a genetic screen and effects on catalysis by the recombinant proteins. Adv Enzyme Regul (2004) 0.94
The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science (2007) 9.86
Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr Biol (2002) 6.55
Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat Genet (2006) 6.15
N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol (2011) 5.96
Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet (2009) 5.84
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging (2010) 5.49
Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage. Nature (2002) 5.47
HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature (2011) 5.28
Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection. Nat Genet (2006) 5.26
Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu Rev Genet (2004) 5.04
Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet (2007) 4.76
Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet (2009) 4.61
ASPM is a major determinant of cerebral cortical size. Nat Genet (2002) 4.57
Mutations in the pericentrin (PCNT) gene cause primordial dwarfism. Science (2008) 4.04
Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell (2007) 3.93
Private practice is unethical-and doctors should give it up. BMJ (2015) 3.92
Reversal of DNA alkylation damage by two human dioxygenases. Proc Natl Acad Sci U S A (2002) 3.62
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum (2006) 3.45
Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema. J Allergy Clin Immunol (2004) 3.30
Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase. J Biol Chem (2011) 3.21
Gene-targeted mice lacking the Trex1 (DNase III) 3'-->5' DNA exonuclease develop inflammatory myocarditis. Mol Cell Biol (2004) 3.19
Identification of microcephalin, a protein implicated in determining the size of the human brain. Am J Hum Genet (2002) 3.13
Human DNA repair genes, 2005. Mutat Res (2005) 3.09
Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet (2007) 2.81
2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol (2010) 2.75
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat Genet (2012) 2.63
Protein kinase cδ deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation. Arthritis Rheum (2013) 2.60
Degos disease: a C5b-9/interferon-α-mediated endotheliopathy syndrome. Am J Clin Pathol (2011) 2.50
Use of a modified informed consent process among vulnerable patients: a descriptive study. J Gen Intern Med (2006) 2.46
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol (2013) 2.36
Repair of alkylated DNA: recent advances. DNA Repair (Amst) (2006) 2.34
tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia. Nat Genet (2008) 2.28
The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death. Mol Cell (2006) 2.21
SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage. Blood (2013) 2.18
Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations. Am J Hum Genet (2009) 2.09
Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54. Am J Hum Genet (2010) 2.08
Activity energy expenditure and incident cognitive impairment in older adults. Arch Intern Med (2011) 2.07
Noninvasive measurement of skin autofluorescence is increased in patients with systemic sclerosis: an indicator of increased advanced glycation endproducts? J Rheumatol (2012) 2.03
Gene-targeted mice lacking the Ung uracil-DNA glycosylase develop B-cell lymphomas. Oncogene (2003) 2.02
An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med (2008) 1.95
Demethylation of 3-methylthymine in DNA by bacterial and human DNA dioxygenases. J Biol Chem (2004) 1.94
An update of the International Society of Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation (PE). J Sex Med (2014) 1.91
A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J Mol Med (Berl) (2007) 1.88
Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nat Genet (2011) 1.84
Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumors. Cancer Res (2004) 1.82
Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. Nat Genet (2012) 1.82
ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation. Nat Genet (2008) 1.78
A DNA polymerase-{alpha}{middle dot}primase cofactor with homology to replication protein A-32 regulates DNA replication in mammalian cells. J Biol Chem (2008) 1.77
Physical activity over the life course and its association with cognitive performance and impairment in old age. J Am Geriatr Soc (2010) 1.76
Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol (2008) 1.76
Mutations in the pre-replication complex cause Meier-Gorlin syndrome. Nat Genet (2011) 1.74
The crystal structure of TREX1 explains the 3' nucleotide specificity and reveals a polyproline II helix for protein partnering. J Biol Chem (2007) 1.66
An advance directive redesigned to meet the literacy level of most adults: a randomized trial. Patient Educ Couns (2007) 1.63
Recognizable phenotypes associated with intracranial calcification. Dev Med Child Neurol (2012) 1.63
SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardi-goutières syndrome-associated mutations. Hum Mutat (2012) 1.61
International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med (2010) 1.60
Recent progress on the Ada response for inducible repair of DNA alkylation damage. Oncogene (2002) 1.59
Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: a multicenter trial. J Periodontol (2004) 1.59
Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention. Cancer Prev Res (Phila) (2012) 1.59
The TREX1 double-stranded DNA degradation activity is defective in dominant mutations associated with autoimmune disease. J Biol Chem (2008) 1.58
A multicentre study on the reliability of qualitative and quantitative nail-fold videocapillaroscopy assessment. Rheumatology (Oxford) (2011) 1.57
DNA repair: from molecular mechanism to human disease. DNA Repair (Amst) (2006) 1.56
Minimal methylated substrate and extended substrate range of Escherichia coli AlkB protein, a 1-methyladenine-DNA dioxygenase. J Biol Chem (2003) 1.53
Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J Clin Invest (2014) 1.50
A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters. Clin Cancer Res (2010) 1.48
Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2. Am J Hum Genet (2009) 1.47
Intracerebral large artery disease in Aicardi-Goutières syndrome implicates SAMHD1 in vascular homeostasis. Dev Med Child Neurol (2010) 1.47
Clinical and mutational spectrum of Mowat-Wilson syndrome. Eur J Med Genet (2005) 1.46
Summary of the recommendations on sexual dysfunctions in men. J Sex Med (2010) 1.42
DNA base excision repair of uracil residues in reconstituted nucleosome core particles. EMBO J (2002) 1.42
The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians. Cancer Cell (2011) 1.40
5-Fluorouracil incorporated into DNA is excised by the Smug1 DNA glycosylase to reduce drug cytotoxicity. Cancer Res (2007) 1.38